Probiotic Ecologic Barrier added to IBS-D treatment in adults with upper GI symptoms and anxiety, depression, or stress
Official title: The Effects of the Multispecies Probiotic Mixture Ecologic Barrier for Patients With Irritable Bowel Syndrome With Upper Gastrointestinal Symptoms and Having Anxiety, Depression, and Stress Symptoms
Run by Institute of Gastroenterology and Hepatology, Vietnam · NCT07656623 · Data updated 2026-11-12
This trial tests whether Ecologic Barrier probiotics added to standard IBS-D treatment can improve IBS symptoms and also help with anxiety, depression, or stress
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Institute of Gastroenterology and Hepatology, Vietnam Academic / other |
| Locations | 1 site (Hanoi, Hanoi) |
| Status | Recruiting |
| Started | June 1, 2024 |
| Main results expected | June 30, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | June 18, 2026 |
| Trial ID | NCT07656623 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with IBS-D and at least one upper GI symptom plus elevated anxiety, depression, or stress scores, undergoing planned endoscopy/colonoscopy.
✕Probably not a fit
Patients without IBS-D symptoms, without upper GI symptoms, or without elevated anxiety/depression/stress may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares standard IBS-D treatment with and without the Ecologic Barrier probiotic. Participants have IBS-D and at least one upper GI symptom plus anxiety, depression, or stress. The probiotic is added for one of the two initial months, with follow-up to assess changes in IBS severity, upper GI symptoms, and mental health scores, alongside safety monitoring. Endoscopy-assisted eligibility and exclusion criteria help define the population. Results could show whether adding Ecologic Barrier provides additional symptom relief and what adverse events may occur.
Why it matters
Potential benefit: If successful, adding Ecologic Barrier could offer extra relief for IBS symptoms and coexisting anxiety/depression/stress.
How similar studies have gone: Other studies with multispecies probiotics have shown potential benefits in IBS symptoms and GI comfort, but responses vary by strain and population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Indication for upper endoscopy and colonoscopy; * Diagnosed with IBS-D according to Rome IV criteria; * Presence of at least one upper gastrointestinal symptom, including: retrosternal burning, reflux, epigastric pain, epigastric burning, postprandial discomfort, early satiety, abdominal bloating, belching, sour regurgitation, nausea/vomiting; * Manifestations of anxiety, depression, or stress, with at least one of the three DASS-21 subscale scores exceeding the normal threshold (depression score \>9 and/or anxiety score \>7 and/or stress score \>14). Exclusion Criteria: * Positive for Helicobacter pylori by rapid urease test during endoscopy or by 13C-urea breath test; * Currently using anxiolytic or antidepressant medication; * Currently or previously used antibiotics within the past month; * Currently or previously used symptomatic treatment, probiotics, or proton pump inhibitors (PPI) within the past two weeks; * History of gastrointestinal surgery; * Endoscopic findings of organic lesions: ulcer, acute inflammation, colonic polyp \>5 mm, or colonic polyp \<5 mm with suspected neoplasia; * Pregnant or breastfeeding women.
Where it's running
-
Institute of Gastroenterology and Hepatology
Hanoi, Hanoi, Vietnam Recruiting
Study contacts
- Study coordinator: Hang V Dao, PhD
- Email: hangdao.fsh@gmail.com
- Phone: +84 987988075
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating Live SK08 Powder for Treating IBS-D
This study is testing if Live SK08 Powder can help people with Irritable Bowel Syndrome and diarrhea feel better compared to a placebo.
-
Gelsectan treatment for adults with diarrhea-predominant IBS
This trial tests whether Gelsectan, alone or combined with an antispasmodic, helps adults in Vietnam who have diarrhea-predominant IBS feel better and have fewer symptoms.
-
Effect of Tong-Xie-Yao-Fang on diarrhea-predominant IBS
This study is testing if a traditional Chinese medicine called Tong-Xie-Yao-Fang can help people with diarrhea-predominant irritable bowel syndrome feel better.
-
Gelsectan® for treating diarrhea-predominant irritable bowel syndrome
This study is testing if Gelsectan® can help people with diarrhea-predominant irritable bowel syndrome feel better.
-
Repeated transcranial magnetic stimulation to treat diarrhea-predominant irritable bowel syndrome
This study will test whether repeated transcranial magnetic stimulation (rTMS) can reduce diarrhea, abdominal pain, and improve quality of life in adults with IBS-D.
-
Using Transcranial Magnetic Stimulation and Probiotics to Treat IBS-D
This study is testing if a combination of brain stimulation and probiotics can help people with diarrhea-predominant IBS feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.